These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27507031)

  • 1. [Therapeutic management of poorly differentiated neuroendocrine lung tumors and neuroendocrine carcinomas of the digestive system].
    Pellat A; Wislez M; Svrcek M; Hammel P; Afchain P; André T
    Bull Cancer; 2016 Oct; 103(10):880-895. PubMed ID: 27507031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroendocrine carcinoma of the digestive tract: a literature review].
    Jacob J; Chargari C; Helissey C; Ferrand FR; Ceccaldi B; Le Moulec S; Bauduceau O; Fayolle M; Védrine L
    Rev Med Interne; 2013 Nov; 34(11):700-5. PubMed ID: 23871177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current concepts in the diagnosis and management of poorly differentiated gastrointestinal neuroendocrine carcinomas.
    Koumarianou A; Chatzellis E; Boutzios G; Tsavaris N; Kaltsas G
    Endokrynol Pol; 2013; 64(1):60-72. PubMed ID: 23450449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas.
    Iwasa S; Morizane C; Okusaka T; Ueno H; Ikeda M; Kondo S; Tanaka T; Nakachi K; Mitsunaga S; Kojima Y; Hagihara A; Hiraoka N
    Jpn J Clin Oncol; 2010 Apr; 40(4):313-8. PubMed ID: 20047862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroendocrine tumors: analysis of 252 cases].
    Chi YH; Jiang WC; Du F; Sun YK; Song Y; Yang L; Zhou AP; Wang JW
    Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):67-70. PubMed ID: 23648305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Small cell neuroendocrine carcinoma of the uterine cervix: Report of six cases and a review of the literature].
    Bellefqih S; Khalil J; Mezouri I; Kebdani T; Benjaafar N
    Cancer Radiother; 2014 Jun; 18(3):201-7. PubMed ID: 24656987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens.
    Shimada Y; Niho S; Ishii G; Hishida T; Yoshida J; Nishimura M; Yoh K; Goto K; Ohmatsu H; Ohe Y; Nagai K
    Lung Cancer; 2012 Mar; 75(3):368-73. PubMed ID: 21920624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study.
    Hainsworth JD; Spigel DR; Litchy S; Greco FA
    J Clin Oncol; 2006 Aug; 24(22):3548-54. PubMed ID: 16877720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of small cell lung cancer.
    Morabito A; Carillio G; Daniele G; Piccirillo MC; Montanino A; Costanzo R; Sandomenico C; Giordano P; Normanno N; Perrone F; Rocco G; Di Maio M
    Crit Rev Oncol Hematol; 2014 Sep; 91(3):257-70. PubMed ID: 24767978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of chemotherapeutic treatment outcomes of advanced extrapulmonary neuroendocrine carcinomas and advanced small-cell lung carcinoma.
    Terashima T; Morizane C; Hiraoka N; Tsuda H; Tamura T; Shimada Y; Kaneko S; Kushima R; Ueno H; Kondo S; Ikeda M; Okusaka T
    Neuroendocrinology; 2012; 96(4):324-32. PubMed ID: 22572060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy in small-cell lung cancer: where should it go?
    Paumier A; Le Péchoux C
    Lung Cancer; 2010 Aug; 69(2):133-40. PubMed ID: 20605651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.
    Winther-Larsen A; Hoffmann L; Moeller DS; Khalil AA; Knap MM
    Acta Oncol; 2015; 54(9):1574-81. PubMed ID: 26203924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and efficacy of combined cisplatin and irinotecan chemotherapy for poorly differentiated neuroendocrine carcinomas.
    Nakano K; Takahashi S; Yuasa T; Nishimura N; Mishima Y; Sakajiri S; Yokoyama M; Tsuyama N; Ishikawa Y; Hatake K
    Jpn J Clin Oncol; 2012 Aug; 42(8):697-703. PubMed ID: 22701038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas.
    Rieber J; Schmitt J; Warth A; Muley T; Kappes J; Eichhorn F; Hoffmann H; Heussel CP; Welzel T; Debus J; Thomas M; Steins M; Rieken S
    Eur J Med Res; 2015 Aug; 20(1):64. PubMed ID: 26272455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-cell lung cancer.
    van Meerbeeck JP; Fennell DA; De Ruysscher DK
    Lancet; 2011 Nov; 378(9804):1741-55. PubMed ID: 21565397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Poorly-differentiated neuroendocrine carcinoma of ascending colon with liver metastases successfully treated with carboplatin and etoposide].
    Akiyama S; Niitani T; Narasaka T; Ohto T; Gamoh M
    Gan To Kagaku Ryoho; 2011 Jul; 38(7):1209-12. PubMed ID: 21772114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine carcinoma of unknown primary site.
    Spigel DR; Hainsworth JD; Greco FA
    Semin Oncol; 2009 Feb; 36(1):52-9. PubMed ID: 19179188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of poorly differentiated neuroendocrine carcinoma of the pancreas.
    Gupta A; Duque M; Saif MW
    JOP; 2013 Jul; 14(4):381-3. PubMed ID: 23846932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy in gastroenteropancreatic (GEP) neuroendocrine carcinomas (NEC): a critical view.
    Fazio N; Spada F; Giovannini M
    Cancer Treat Rev; 2013 May; 39(3):270-4. PubMed ID: 22819619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.